US Stocks
/
Eledon Pharmaceuticals, Inc. Share Price

Eledon Pharmaceuticals, Inc. Share Price

NASDAQ: ELDN | Micro Cap
$2.41
+0.00 (0.00%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Eledon Pharmaceuticals, Inc. Stock Performance

Open
$2.36
Prev. Close
$2.41
Circuit Range
N/A
Day Range
$2.36 - $2.44
Year Range
$1.37 - $4.51
Volume
30,323
Average Traded
$2.40

Eledon Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, Eledon Pharmaceuticals, Inc.'s share price is $2.41. The stock opened at $2.36, compared to its previous close of $2.41. During today's trading session, Eledon Pharmaceuticals, Inc.'s share price traded between $2.36 and $2.44, with an average price of $2.40. Over the past 52 weeks, the stock has recorded a high of $4.51 and a low of $1.37. In terms of performance, Eledon Pharmaceuticals, Inc.'s share price has declined by 33.61% over the last six months and is down 44.21% on a year-on-year basis.

Eledon Pharmaceuticals, Inc. Share Price Chart

$2.36$2.44
L
Show Current Price
H

Eledon Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$197.23M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.19
Revenue (TTM)
$0.00
Return On Equity (TTM)
-292.10%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-87.48%

Eledon Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$16.13-$13.13-$36.94-$30.24
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A18.60%-181.34%18.14%

Eledon Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$87.97-$116.54-$36.18-$45.62
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-32.48%68.95%-26.09%

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Eledon Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.50
$2.42
-4.35%
Sep 2026
$2.94
$2.53
-23.80%
Aug 2026
$3.48
$3.32
-1.48%
Jul 2026
$4.00
$3.37
-14.25%
Jun 2026
$3.72
$3.93
+2.88%
May 2026
$3.62
$3.82
+5.23%
Apr 2026
$3.10
$3.63
+17.86%
Mar 2026
$2.57
$3.08
+17.78%
Feb 2026
$2.17
$2.62
+19.41%
Jan 2026
$1.52
$2.19
+45.51%
Dec 2025
$1.60
$1.50
-7.67%
Nov 2025
$4.50
$1.63
-62.27%

ELDN Share Price FAQs

What is Eledon Pharmaceuticals, Inc. share price today?

chevron-up
Eledon Pharmaceuticals, Inc. share price today is $2.41 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Eledon Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Eledon Pharmaceuticals, Inc. stock is $4.51, while the 52 week low is $1.37 as of 9 Oct '26.

What is ELDN's market capitalisation today?

chevron-up
ELDN market capitalisation is $197.23M as of October 9, 2026, at 4:47 pm IST.

What is ELDN's net income for the last quarter?

chevron-up
ELDN's net income for the last quarter is -30.24B USD.

What is the 5 year returns of ELDN?

chevron-up
The 5 year returns of ELDN is -51.80% as on 9 Oct '26.

What is the high & low stock price of ELDN today?

chevron-up
ELDN stock price hit a high of $2.44 and low of $2.36 as of 9 Oct '26.

Can I buy ELDN shares in India?

chevron-up
Yes. You can buy ELDN in India by opening an international trading account.